PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado Ekiti, Nigeria; Molecular Biology and Molecular Simulation Center (Mols&Sims), Ado Ekiti, Nigeria. Electronic address: olaposi.omotuyi@abuad.edu.ng.\', \'Department of Pharmaceutical Chemistry, College of Pharmacy, Afe Babalola University, Ado-Ekiti, Nigeria.\', \'Centre for Genomics Research and Innovation, National Biotechnology Agency, Nigeria.\', \'Institute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado Ekiti, Nigeria.\', \'London School of Hygiene and Tropical Medicine, London, United Kingdom.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0010-4825(22)00018-X10.1016/j.compbiomed.2022.105226
?:doi
?:hasPublicationType
?:journal
  • Computers in biology and medicine
is ?:pmid of
?:pmid
?:pmid
  • 35066447
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.591
?:rankingScore_hIndex
  • 68
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 Omicron spike glycoprotein receptor binding domain exhibits super-binder ability with ACE2 but not convalescent monoclonal antibody.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35066447>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35066447>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all